Test Price
7,000 AED✅ Home Collection Available
Oncomine Focus Panel + PD‑L1 Test in UAE – Comprehensive Genomic & Immunotherapy Profiling
Executive Summary & Core Metrics
Executive Summary
This definitive genomic profiling test merges 52‑gene next‑generation sequencing (NGS) with PD‑L1 immunohistochemistry (IHC) on a single archived tumour specimen. ISO‑certified accuracy (99.9% diagnostic sensitivity) is delivered through secure medical courier solid tissue specimen retrieval from any accredited UAE hospital. Results are reported within 20–25 working days, accompanied by telephonic post‑test clinical guidance from our oncology team. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Oncomine Focus Panel + PD‑L1 test is a single‑tissue comprehensive genomic profile that simultaneously interrogates 52 actionable cancer genes and quantifies PD‑L1 protein expression. This dual‑method workflow (NGS + IHC) delivers a thorough molecular blueprint to guide targeted therapy and immune checkpoint inhibitor decisions, all within a strictly regulated UAE healthcare framework.
| Feature | Oncomine Focus + PD‑L1 Panel | Standard Single‑Gene + PD‑L1 IHC |
|---|---|---|
| Precision | Multi‑gene NGS panel covering 52 genes + IHC | Single‑gene PCR/sanger ± separate IHC |
| Methodology | Next‑Generation Sequencing & Immunohistochemistry | Polymerase chain reaction / Immunohistochemistry |
| Turnaround Time | 20–25 working days | 10–15 working days (fewer markers) |
| Therapeutic Guidance | Simultaneous targeted therapy + immunotherapy prediction | Limited to one drug target or PD‑L1 alone |
Physician Insight & Safety Protocols
“As your diagnostic radiology specialist, I want you to understand that this test provides a powerful molecular compass for your oncology team. The genomic alterations and PD‑L1 expression we identify must be carefully correlated with your clinical history and imaging findings. I am available to help clarify what these results mean for your personalised treatment plan.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication & Treatment Advisory
⚠ Medication Advisory
Do not discontinue any prescribed medication, chemotherapy, or targeted therapy without consulting your managing physician. This test is a profiling tool; treatment changes must only be made under direct medical supervision.
Safety & Exclusion Criteria
- Exclusion: Not designed as a first‑line screening for asymptomatic individuals; requires clinical suspicion of a solid tumour confirmed by a specialist. Not validated for haematological malignancies.
- Prescription: A valid doctor’s prescription is mandatory. The test may be performed without a prescription only for urgent preoperative oncological clearance or pregnancy‑associated tumour workup, subject to physician approval.
- ER Red Flags: If you experience acute worsening of pain, new neurological symptoms (seizures, vision changes, limb weakness), or sudden bleeding while awaiting results, go to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What exactly does the Oncomine Focus Panel + PD‑L1 test measure?
This comprehensive genomic profiling test simultaneously analyzes 52 cancer‑associated genes and PD‑L1 protein expression from a single tumour tissue specimen, revealing actionable mutations and immunotherapy eligibility. The dual NGS + IHC approach provides a complete molecular picture to guide treatment decisions.
2. How long do results take, and how will I receive them?
Results are delivered within 20–25 working days, ensuring thorough next‑generation sequencing and immunohistochemistry interpretation. Your oncology team will discuss the findings in a secure consultation, and a written report will be provided electronically or in print as per your preference.
3. Do I need to stop any medications before the test?
No changes to your current treatment are required; continue all prescribed medications as directed, because stopping them could compromise your health and the validity of the genomic results. If you have concerns about any medication, please discuss them with your managing physician before the specimen is collected.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA) and adheres to all applicable UAE federal laws governing healthcare data and patient privacy:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring your personal and genomic data are processed lawfully, transparently, and securely.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure handling, storage, and transmission of digital health records and telemedicine communications.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing the legal framework for clinical safety, informed consent, and professional accountability throughout the diagnostic pathway.
All patient data are encrypted and stored within UAE‑based servers. Your consent is obtained prior to any genomic analysis, and you have the right to access, rectify, or request deletion of your data in accordance with PDPL provisions.
Clinical & Logistical Metadata
| Test Name | Oncomine Focus Panel + PD‑L1 Test |
| Price (AED) | 7,000 AED |
| Turnaround Time | 20–25 working days |
| Sample Type / Matrix | Formalin‑Fixed Paraffin‑Embedded (FFPE) Tumor Tissue Block or Slides — Secure Medical Courier Solid Tissue Specimen Retrieval |
| Methodology Used | Next‑Generation Sequencing (NGS) & Immunohistochemistry (IHC) |
| ICD-10-CM Code | C80.1 (Malignant neoplasm, primary site unknown) |
| LOINC Code | 91846-4 (Oncomine comprehensive assay v3 panel) |
| DHA Facility License & Lab Address | DHA Facility License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians